摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1R,2S,9S)-11-(2,2-dimethylpropyl)-7,11-diazatricyclo[7.3.1.02,7]tridecane

中文名称
——
中文别名
——
英文名称
(1R,2S,9S)-11-(2,2-dimethylpropyl)-7,11-diazatricyclo[7.3.1.02,7]tridecane
英文别名
(1R,5S,11aS)-3-neopentyldecahydro-1H-1,5-methanopyrido[1,2-a][1,5]diazocine;(1R,2S,9S)-11-(2,2-dimethylpropyl)-7,11-diazatricyclo[7.3.1.02,7]tridecane
(1R,2S,9S)-11-(2,2-dimethylpropyl)-7,11-diazatricyclo[7.3.1.0<sup>2,7</sup>]tridecane化学式
CAS
——
化学式
C16H30N2
mdl
——
分子量
250.428
InChiKey
XKTIVYUOIHHBBU-ZNMIVQPWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    6.5
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为产物:
    参考文献:
    名称:
    Evaluation of (+)-Sparteine-like Diamines for Asymmetric Synthesis
    摘要:
    Three new (+)-sparteine-like diamines were prepared from (-)-cytisine and evaluated as sparteine surrogates in the alpha-lithiation rearrangement of cyclooctene oxide and the palladium(II)/diamine catalyzed oxidative kinetic resolution of I-indanol. The new diamines exhibited opposite enantioselectivity to that observed with (-)-sparteine but increasing the steric hindrance of the N-alkyl group beyond N-Et had a detrimental effect on enantioselectivity. The optimal N-Me diamine was evaluated with much success in five other (-)-sparteine-mediated processes involving different metals (lithium, magnesium, and copper) and different types of reaction mechanisms.
    DOI:
    10.1021/jo049182w
点击查看最新优质反应信息

文献信息

  • PROCESSES AND INTERMEDIATES
    申请人:Vertex Pharmaceuticals Incorporated
    公开号:US20130096277A1
    公开(公告)日:2013-04-18
    A process for preparing enantioselectively a compound of formula I-1a or I-1b: over a compound of formulas I-2-I-7:
  • Evaluation of (+)-Sparteine-like Diamines for Asymmetric Synthesis
    作者:Michael J. Dearden、Matthew J. McGrath、Peter O'Brien
    DOI:10.1021/jo049182w
    日期:2004.8.1
    Three new (+)-sparteine-like diamines were prepared from (-)-cytisine and evaluated as sparteine surrogates in the alpha-lithiation rearrangement of cyclooctene oxide and the palladium(II)/diamine catalyzed oxidative kinetic resolution of I-indanol. The new diamines exhibited opposite enantioselectivity to that observed with (-)-sparteine but increasing the steric hindrance of the N-alkyl group beyond N-Et had a detrimental effect on enantioselectivity. The optimal N-Me diamine was evaluated with much success in five other (-)-sparteine-mediated processes involving different metals (lithium, magnesium, and copper) and different types of reaction mechanisms.
查看更多

同类化合物

铺地蜈蚣碱 诺利溴铵 蔓杉石松宁 羽扇豆碱 羽扇豆喃 硫双萍蓬定 甲基6-氧代-1,3,4,6-四氢-2H-喹嗪-9-羧酸酯 狭叶碱 牡丹草佛明 溴化八氢5-甲基-1-[(2-甲基丙酰)氧代]-2H-喹嗪正离子 吲哚霉素 吐根胺 化合物 T29527 内-六氢-8-羟基-2,6-亚甲基-2H-喹嗪-3 八氢-喹啉嗪-3-羧酸乙酯 八氢-4H-喹嗪 八氢-4-甲基-2H-喹嗪 八氢-2H-喹嗪-1-基二甲基氨基甲酸酯盐酸(1:1) 八氢-1-(5-甲氧基-1H-吲哚-3-基)-2H-喹嗪 八氢-1-(5-甲基-1H-吲哚-3-基)-2H-喹嗪 乙基8-羟基-6-氧代-1,3,4,6-四氢-2H-喹嗪-9-羧酸酯 乙基8-氯-4-氧代-4H-喹嗪-3-羧酸酯 乙基6-氧代-1,3,4,6-四氢-2H-喹嗪-9-羧酸酯 乙基4-氧代-4H-喹嗪-3-羧酸酯 N-[[(1S,9aR)-2,3,4,6,7,8,9,9a-八氢-1H-喹嗪-1-基]甲基]-4-氨基-5-氯-2-甲氧基苯甲酰胺 N-[[(1S,9aR)-2,3,4,6,7,8,9,9a-八氢-1H-喹嗪-1-基]甲基]-2-甲氧基-5-氨基磺酰基苯甲酰胺 N-[[(1S,9aR)-2,3,4,6,7,8,9,9a-八氢-1H-喹嗪-1-基]甲基]-2,6-二甲氧基苯甲酰胺 N-[(E)-[(9aR)-六氢-2H喹嗪-1(6H)-亚基]甲基]-乙酰胺 N-[(1S,9aR)-八氢-2H-喹嗪-1-基甲基]-4-[(E)-苯基二氮烯基]-5,6,7,8-四氢萘-1-胺 8-氯-1-乙基-4-氧代-4H-喹啉嗪-3-羧酸乙酯 8-氨基-4-氧代-4H-喹嗪-3-羧酸 6,6-二甲基-2,3,4,7,8,9,10,10B-八氢-1H-环戊并[h]喹嗪 6,6-二甲基-1,2,3,4,7,7a,8,9,10,11,11a,11b-十二氢吡啶并[2,1-a]异喹啉 5-羟基-8-氮杂三环[5.3.1.03,8]十一烷-10-酮 5(2H)-异噻唑酮,3-甲基-4-戊基-(9CI) 4-[(E)-(4-氟苯基)二氮烯基]-N-[(1S,9aR)-八氢-2H-喹嗪-1-基甲基]-5,6,7,8-四氢萘-1-胺 3-[二(2-噻吩基)亚甲基]八氢-2H-喹嗪 2H-喹嗪,1,3,4,6,7,9a-六氢- 2H-喹嗪,1,3,4,6,7,8-六氢-9-甲基- 2-羟基-3-甲基喹啉-4-酮 2-甲基-八氢-喹嗪 2-去氢金雀花碱 1-硝基-4-氧代-4H-喹嗪-3-甲酸乙酯 1-甲酰基-4-氧代-4H-羟基喹啉-3-羧酸乙酯 1-环丙基-7-氟-9-甲基-8-[(4aR,7aR)-八氢-6H-吡咯并[3,4-b]吡啶-6-基]-4-羰基-4H-喹嗪-3-羧酸 1-溴-4-氧代-4氢-喹嗪-3-甲酸乙酯 1-{[2-(4-甲氧苄基)-5-(三氟甲基)-1H-苯并咪唑-1-基]甲基}八氢-2H-喹嗪 1-[[(1R,8aR)-2,3,4,5,6,7,8,8a-八氢-1H-喹嗪-1-基]甲基]哌啶-2,6-二酮 1-(氯甲基)八氢-2H-喹嗪 (4R,9aS)-4-甲基八氢-2H-喹嗪